Achieve Life Sciences, Inc. (ACHV)
NASDAQ: ACHV · Real-Time Price · USD
4.560
-0.130 (-2.77%)
At close: May 26, 2026, 4:00 PM EDT
4.660
+0.100 (2.19%)
Pre-market: May 27, 2026, 5:10 AM EDT
Achieve Life Sciences Employees
Achieve Life Sciences had 28 employees as of December 31, 2025. The number of employees increased by 3 or 12.00% compared to the previous year.
Employees
28
Change (1Y)
3
Growth (1Y)
12.00%
Revenue / Employee
n/a
Profits / Employee
-$1,856,750
Market Cap
468.13M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 28 | 3 | 12.00% |
| Dec 31, 2024 | 25 | 3 | 13.64% |
| Dec 31, 2023 | 22 | 2 | 10.00% |
| Dec 31, 2022 | 20 | 4 | 25.00% |
| Dec 31, 2021 | 16 | 3 | 23.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 754 |
| 4D Molecular Therapeutics | 196 |
| ADC Therapeutics | 193 |
| Sutro Biopharma | 137 |
| Ocugen | 116 |
| Adlai Nortye | 109 |
| Upstream Bio | 75 |
| Fulcrum Therapeutics | 55 |
ACHV News
- 7 days ago - Achieve Life Sciences Presents Safety Data from 52 Weeks of Continuous Cytisinicline Treatment - GlobeNewsWire
- 14 days ago - Achieve Life Sciences files prospectus for resale of shares by holders - TheFly
- 14 days ago - Achieve Life Sciences Q1 Earnings Call Highlights - MarketBeat
- 14 days ago - Achieve Life Sciences Earnings Call Transcript: Q1 2026 - Transcripts
- 14 days ago - Achieve Life Sciences Earnings release: Q1 2026 - Filings
- 14 days ago - Achieve Life Sciences Quarterly report: Q1 2026 - Filings
- 14 days ago - Achieve Life Sciences Registration statement: Registration filing - Filings
- 14 days ago - Achieve Life Sciences reports Q1 EPS (19c), consensus (30c) - TheFly